The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm

Detalhes bibliográficos
Autor(a) principal: João Pedro Cerveira Gonçalves
Data de Publicação: 2023
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/150342
Resumo: Cytosine modifications at the 5-carbon position play an important role in the regulation of gene expression, and its deregulation is considered a hallmark of cancer. Recent studies demonstrate that 5-hydroxymethylcytosine (5-hmC) generated through 5-methylcytosine (5-mC) oxidation is significantly depleted in several human cancers. Although its role in tumour progression is still unknown, the 5-hmC loss has been proposed as a marker of tumour malignancy. Concerning thyroid tumours, the literature is scarce, and the studies are sparse in a number of cases and diversity of histotypes, not allowing clear conclusions. In this work, we evaluated the levels of 5-hmC, by immunohistochemistry, in a retrospective series of 318 thyroid tumours, including benign, low-risk, and malignant tumours, classified according to the 4th edition of WHO, and correlated its expression with demographic and clinicopathological features of the patients and tumours, aiming to verify whether 5-hmC levels can be used as a diagnostic, prognostic or therapeutic marker. Our data show a significant association between loss of expression of 5-hmC and extrathyroidal extension, invasive/infiltrative capsule status, lymphovascular invasion, bilaterality, multifocality, tumour malignancy, and an unprecedented link with oncocytic morphology. Additionally, in a subgroup of 183 papillary thyroid carcinoma (PTC) cases, we also observed a statistically significant loss of 5-hmC in cases with TERT promoter mutations and distant metastasis. Our study evidences an important role for 5-hmC in thyroid tumourigenesis and indicates that 5-hmC levels have the potential to be used as a diagnostic and prognostic marker, however, more studies are needed to fully verify its potential.
id RCAP_a50ba726d35ebff7086b9e66e47c10c0
oai_identifier_str oai:repositorio-aberto.up.pt:10216/150342
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasmCiências da saúdeHealth sciencesCytosine modifications at the 5-carbon position play an important role in the regulation of gene expression, and its deregulation is considered a hallmark of cancer. Recent studies demonstrate that 5-hydroxymethylcytosine (5-hmC) generated through 5-methylcytosine (5-mC) oxidation is significantly depleted in several human cancers. Although its role in tumour progression is still unknown, the 5-hmC loss has been proposed as a marker of tumour malignancy. Concerning thyroid tumours, the literature is scarce, and the studies are sparse in a number of cases and diversity of histotypes, not allowing clear conclusions. In this work, we evaluated the levels of 5-hmC, by immunohistochemistry, in a retrospective series of 318 thyroid tumours, including benign, low-risk, and malignant tumours, classified according to the 4th edition of WHO, and correlated its expression with demographic and clinicopathological features of the patients and tumours, aiming to verify whether 5-hmC levels can be used as a diagnostic, prognostic or therapeutic marker. Our data show a significant association between loss of expression of 5-hmC and extrathyroidal extension, invasive/infiltrative capsule status, lymphovascular invasion, bilaterality, multifocality, tumour malignancy, and an unprecedented link with oncocytic morphology. Additionally, in a subgroup of 183 papillary thyroid carcinoma (PTC) cases, we also observed a statistically significant loss of 5-hmC in cases with TERT promoter mutations and distant metastasis. Our study evidences an important role for 5-hmC in thyroid tumourigenesis and indicates that 5-hmC levels have the potential to be used as a diagnostic and prognostic marker, however, more studies are needed to fully verify its potential.2023-05-242023-05-24T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/10216/150342TID:203521803porJoão Pedro Cerveira Gonçalvesinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-16T01:25:00Zoai:repositorio-aberto.up.pt:10216/150342Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:39:37.647141Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
title The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
spellingShingle The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
João Pedro Cerveira Gonçalves
Ciências da saúde
Health sciences
title_short The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
title_full The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
title_fullStr The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
title_full_unstemmed The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
title_sort The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm
author João Pedro Cerveira Gonçalves
author_facet João Pedro Cerveira Gonçalves
author_role author
dc.contributor.author.fl_str_mv João Pedro Cerveira Gonçalves
dc.subject.por.fl_str_mv Ciências da saúde
Health sciences
topic Ciências da saúde
Health sciences
description Cytosine modifications at the 5-carbon position play an important role in the regulation of gene expression, and its deregulation is considered a hallmark of cancer. Recent studies demonstrate that 5-hydroxymethylcytosine (5-hmC) generated through 5-methylcytosine (5-mC) oxidation is significantly depleted in several human cancers. Although its role in tumour progression is still unknown, the 5-hmC loss has been proposed as a marker of tumour malignancy. Concerning thyroid tumours, the literature is scarce, and the studies are sparse in a number of cases and diversity of histotypes, not allowing clear conclusions. In this work, we evaluated the levels of 5-hmC, by immunohistochemistry, in a retrospective series of 318 thyroid tumours, including benign, low-risk, and malignant tumours, classified according to the 4th edition of WHO, and correlated its expression with demographic and clinicopathological features of the patients and tumours, aiming to verify whether 5-hmC levels can be used as a diagnostic, prognostic or therapeutic marker. Our data show a significant association between loss of expression of 5-hmC and extrathyroidal extension, invasive/infiltrative capsule status, lymphovascular invasion, bilaterality, multifocality, tumour malignancy, and an unprecedented link with oncocytic morphology. Additionally, in a subgroup of 183 papillary thyroid carcinoma (PTC) cases, we also observed a statistically significant loss of 5-hmC in cases with TERT promoter mutations and distant metastasis. Our study evidences an important role for 5-hmC in thyroid tumourigenesis and indicates that 5-hmC levels have the potential to be used as a diagnostic and prognostic marker, however, more studies are needed to fully verify its potential.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-24
2023-05-24T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/150342
TID:203521803
url https://hdl.handle.net/10216/150342
identifier_str_mv TID:203521803
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136302466072576